Gastroenterology Book

http://www.fpnotebook.com/

Trimethobenzamide

Aka: Trimethobenzamide, Tigan
  1. Indications
    1. Emesis of central causes
  2. Dosing
    1. Adults: 250 mg PO or 200 mg IM/PR q6-8 hours
    2. Child (15 to 40 kg): 100-200 mg PO/PR tid to qid
    3. Child (<15 kg): 100 mg PR tid to qid
      1. Do not use in newborns
  3. Mechanism
    1. Centrally acting non-phenothiazine Antiemetic
  4. References
    1. Johnson (1993) Harriet Lane, Mosby, p. 521
    2. (2002) Tarascon Pocket Pharmacopoeia, p. 67

trimethobenzamide (C0077163)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C100146
SnomedCT 14814001, 372657005
English trimethobenzamide, trimethobenzamide [Chemical/Ingredient], Trimethobenzamide, Trimethobenzamide (product), Trimethobenzamide (substance), TRIMETHOBENZAMIDE
Spanish trimetobenzamida (producto), trimetobenzamida (sustancia), trimetobenzamida
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Tigan (C0733768)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C100146
English Tigan, tigan, Monarch brand of trimethobenzamide monohydrochloride
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree